Identification of an optimal prolactin threshold to determine prolactinoma size using receiver operating characteristic analysis
Abstract Prolactinomas represent the most common type of secretory pituitary neoplasms, with a therapeutic management that varies considerably based on tumour size and degree of hyperprolactinemia. The aim of the current study was to evaluate the relationship between serum prolactin (PRL) concentrat...
Guardado en:
Autores principales: | Bianca M. Leca, Maria Mytilinaiou, Marina Tsoli, Andreea Epure, Simon J. B. Aylwin, Gregory Kaltsas, Harpal S. Randeva, Georgios K. Dimitriadis |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3d1f5a9291d64e33bc4fcb33f13e7454 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Somatic SF3B1 hotspot mutation in prolactinomas
por: Chuzhong Li, et al.
Publicado: (2020) -
The recurrence of prolactinoma after withdrawal of dopamine agonist: a systematic review and meta-analysis
por: Yunzhi Zou, et al.
Publicado: (2021) -
Persistent bone impairment despite long-term control of hyperprolactinemia and hypogonadism in men and women with prolactinomas
por: Lukas Andereggen, et al.
Publicado: (2021) -
Connections between prolactin and ovarian cancer.
por: Amira Alkharusi, et al.
Publicado: (2021) -
The role of MAPK11/12/13/14 (p38 MAPK) protein in dopamine agonist-resistant prolactinomas
por: Shuman Wang, et al.
Publicado: (2021)